These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Blood pressure and stroke; the PROGRESS trial. He FJ; MacGregor GA J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116 [No Abstract] [Full Text] [Related]
23. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study]. Scheen AJ Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395 [TBL] [Abstract][Full Text] [Related]
24. Trials on blood pressure-lowering and secondary stroke prevention. Chalmers J Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902 [TBL] [Abstract][Full Text] [Related]
25. Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain. Davis SM; Donnan GA Stroke; 2003 May; 34(5):1335-6. PubMed ID: 12702835 [No Abstract] [Full Text] [Related]
26. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key. Bath P Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833 [No Abstract] [Full Text] [Related]
27. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M; Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329 [TBL] [Abstract][Full Text] [Related]
28. ACE inhibitors and stroke: new considerations. Sica DA J Clin Hypertens (Greenwich); 2002; 4(2):126-9, 133. PubMed ID: 11927795 [No Abstract] [Full Text] [Related]
29. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Ferrari R Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572 [TBL] [Abstract][Full Text] [Related]
30. [Antihypertensive agents after cerebral stroke are more effective than expected]. Rumboldt Z Lijec Vjesn; 2001; 123(9-10):283-4. PubMed ID: 11845587 [No Abstract] [Full Text] [Related]
32. The EUROPA trial. Kwaku M; Burman KD; Becker KL; Mannan M Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667758 [No Abstract] [Full Text] [Related]
33. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480 [TBL] [Abstract][Full Text] [Related]
34. Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS). Ninomiya T; Donnan G; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Chalmers J; Woodward M; Neal B; Stroke; 2009 Jun; 40(6):2111-5. PubMed ID: 19359647 [TBL] [Abstract][Full Text] [Related]